| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACTN4
|
actinin, alpha 4
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANXA2
|
annexin A2
|
|
ANXA5
|
annexin A5
|
|
APOB
|
apolipoprotein B
|
|
APOE
|
apolipoprotein E
|
|
APOM
|
apolipoprotein M
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
AVP
|
arginine vasopressin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BEST1
|
bestrophin 1
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
C5
|
complement component 5
|
|
C9
|
complement component 9
|
|
CCDC114
|
coiled-coil domain containing 114
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD28
|
CD28 molecule
|
|
CD38
|
CD38 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CDAN1
|
codanin 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRYBB2
|
crystallin, beta B2
|
|
CRYGB
|
crystallin, gamma B
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
DCC
|
DCC netrin 1 receptor
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DES
|
desmin
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
E2F1
|
E2F transcription factor 1
|
|
EFNA4
|
ephrin-A4
|
|
EGF
|
epidermal growth factor
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EMD
|
emerin
|
|
EN2
|
engrailed homeobox 2
|
|
ENAM
|
enamelin
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA10
|
EPH receptor A10
|
|
EPHB6
|
EPH receptor B6
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ETV4
|
ets variant 4
|
|
EVC2
|
Ellis van Creveld syndrome 2
|
|
F11
|
coagulation factor XI
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FHL1
|
four and a half LIM domains 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXP3
|
forkhead box P3
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GALNS
|
galactosamine (N-acetyl)-6-sulfatase
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GATA4
|
GATA binding protein 4
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLI2
|
GLI family zinc finger 2
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HFE
|
hemochromatosis
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HNRNPH2
|
heterogeneous nuclear ribonucleoprotein H2 (H')
|
|
HNRNPH3
|
heterogeneous nuclear ribonucleoprotein H3 (2H9)
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HNRNPLL
|
heterogeneous nuclear ribonucleoprotein L-like
|
|
HNRNPM
|
heterogeneous nuclear ribonucleoprotein M
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
HOXC13
|
homeobox C13
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
IVD
|
isovaleryl-CoA dehydrogenase
|
|
JAZF1
|
JAZF zinc finger 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIAA0907
|
KIAA0907
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LOR
|
loricrin
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEFV
|
Mediterranean fever
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR205
|
microRNA 205
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MRPS12
|
mitochondrial ribosomal protein S12
|
|
MSH2
|
mutS homolog 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH2
|
notch 2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUP214
|
nucleoporin 214kDa
|
|
OPTN
|
optineurin
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDCD1
|
programmed cell death 1
|
|
PGR
|
progesterone receptor
|
|
PHKG2
|
phosphorylase kinase, gamma 2 (testis)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLIN2
|
perilipin 2
|
|
PMP22
|
peripheral myelin protein 22
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCSH
|
protein kinase C substrate 80K-H
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RB1
|
retinoblastoma 1
|
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBMXL2
|
RNA binding motif protein, X-linked-like 2
|
|
RP1L1
|
retinitis pigmentosa 1-like 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
SATB1
|
SATB homeobox 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SEPT9
|
septin 9
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SHOX
|
short stature homeobox
|
|
SLC24A5
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 5
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC6A19
|
solute carrier family 6 (neutral amino acid transporter), member 19
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9
|
|
SLC7A4
|
solute carrier family 7, member 4
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMOC1
|
SPARC related modular calcium binding 1
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SRSF5
|
serine/arginine-rich splicing factor 5
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TARDBP
|
TAR DNA binding protein
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TTN
|
titin
|
|
TUBA1B
|
tubulin, alpha 1b
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
USP19
|
ubiquitin specific peptidase 19
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VWF
|
von Willebrand factor
|
|
WDFY2
|
WD repeat and FYVE domain containing 2
|
|
WT1
|
Wilms tumor 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZFYVE26
|
zinc finger, FYVE domain containing 26
|
